Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.20.2
Stockholders' Equity (Tables)
 9 Months Ended
Sep. 30, 2020
Stockholders' Equity Note [Abstract]  
Schedule of warrant and stock option grants
    Warrant Grants     Stock Option Grants     Restricted Stock Units  
    Number of
shares
subject to
warrants		     Weighted-
average
exercise
price per
share		     Number of
shares
subject to
options		     Weighted-
average
exercise
price per
share		     Number of
shares
subject to
restricted
stock units		     Weighted-
average
exercise
price per
share		  
Balance at December 31, 2019     1,311,916     $ 9.35       338,595     $ 5.96       630,303     $                -  
Granted     100,000       4.80       -       -       2,300,845       -  
Exercised     (701,355 )     5.44       (160,291 )     4.26       (46,931 )     -  
Cancelled/Forfeited     -       -       -       -       (475,000 )     -  
Balance at September 30, 2020     710,561     $ 11.42       178,304     $ 3.00       2,409,217     $ -  
Exercisable at September 30, 2020     710,561     $ 11.42       178,304     $ 3.00       2,409,217     $ -  
Schedule of stock-based compensation expense categorized of equity components
    For the three months ended     For the nine months ended  
    September 30,     September 30,  
    2020     2019     2020     2019  
Stock-based compensation expense   $ 1,826,607     $ 433,438     $ 4,183,154     $ 6,283,811  
Schedule of stock-based compensation expense
    For the three months ended     For the nine  months ended  
    September 30,     September 30,  
    2020     2019     2020     2019  
Common stock   $ 1,826,607     $ 359,910     $ 4,183,154     $ 764,807  
Stock option awards     -       73,528       -       196,074  
Transfer of common stock by founders to contractors     -       -       -       5,322,930  
Total   $ 1,826,607     $ 433,438     $ 4,183,154     $ 6,283,811